MCV 5-dose implementation
Implementing 5-dose Measles-Rubella Vaccine Vials in Zambia Research Findings. Dose Per Container Partnership, JSI (2019)
An in-depth overview of the implementation research conducted in Zambia. The following outline some key results:
• The household coverage survey found a statistically significant increase in coverage for both doses. Wastage also decreased statistically significantly in health facilities where 5-dose MR vials were used.
• When using 5-dose vials, healthcare workers frequently reported that they believe they can reach more children.
• An analysis of cold chain equipment in intervention health facilities showed that there was sufficient space to accommodate the small increase in volume that occurred when switching from 10-dose to 5-dose MR vaccine vials.
• The incremental annual costs for switching to 5-dose vials (excluding the value of vaccines) was $0.11.